PRME · Prime Medicine, Inc. · Analyst Estimates
$3.17
-0.19 (-5.52%)
At close · Sep 11
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we concluded that substantial doubt exists about our ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$607.61M
Shares
181.38M
Analyst Estimates
Compare analyst forecasts for Prime Medicine, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1894562
CUSIP
74168J101
13F (30d)
106 filings
106 filers
Visit website
Investor relations